Crossmark

Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients

Crossref DOI link: https://doi.org/10.1186/s12933-020-0990-2

Published Online: 2020-02-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shao, Shih-Chieh

Chang, Kai-Cheng

Lin, Swu-Jane

Chien, Rong-Nan

Hung, Ming-Jui

Chan, Yuk-Ying

Kao Yang, Yea-Huei

Lai, Edward Chia-Cheng https://orcid.org/0000-0002-5852-7652
Funding

Funding for this research was provided by:

Chang Gung Medical Foundation (CMRPG3H1552)

Ministry of Science and Technology of Taiwan (107 2320 B 006 070 MY3)
License Information

Text and Data Mining valid from 2020-02-12

Version of Record valid from 2020-02-12
More Information

Article History

Received: 12 December 2019

Accepted: 16 January 2020

First Online: 12 February 2020

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board (IRB) of Chang Gung Medical Foundation (ID: 201801493B0). The IRB waived the consent requirement because all patients’ personal identities are encrypted by anonymous identification numbers.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below